Cargando…

A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands

Hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels are promising therapeutic targets because of their association with the genesis of several diseases. The identification of selective compounds that alter cAMP-induced ion channel modulation by binding to the cyclic nucleotide-bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wojciechowski, Magdalena N., Schreiber, Sebastian, Jose, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224427/
https://www.ncbi.nlm.nih.gov/pubmed/37242492
http://dx.doi.org/10.3390/ph16050710
_version_ 1785050181828345856
author Wojciechowski, Magdalena N.
Schreiber, Sebastian
Jose, Joachim
author_facet Wojciechowski, Magdalena N.
Schreiber, Sebastian
Jose, Joachim
author_sort Wojciechowski, Magdalena N.
collection PubMed
description Hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels are promising therapeutic targets because of their association with the genesis of several diseases. The identification of selective compounds that alter cAMP-induced ion channel modulation by binding to the cyclic nucleotide-binding domain (CNBD) will facilitate HCN channel-specific drug development. In this study, a fast and protein purification-free ligand-binding approach with a surface-displayed HCN4 C-Linker-CNBD on E. coli is presented. 8-Fluo-cAMP ligand binding was monitored by single-cell analysis via flow cytometry, and a K(d)-value of 173 ± 46 nM was determined. The K(d) value was confirmed by ligand depletion analysis and equilibrium state measurements. Applying increasing concentrations of cAMP led to a concentration-dependent decrease in fluorescence intensity, indicating a displacement of 8-Fluo-cAMP. A K(i)-value of 8.5 ± 2 µM was determined. The linear relationship of IC(50) values obtained for cAMP as a function of ligand concentration confirmed the competitive binding mode: IC(50): 13 ± 2 µM/16 ± 3 µM/23 ± 1 µM/27 ± 1 µM for 50 nM/150 nM/250 nM/500 nM 8-Fluo-cAMP. A similar competitive mode of binding was confirmed for 7-CH-cAMP, and an IC(50) value of 230 ± 41 nM and a K(i) of 159 ± 29 nM were determined. Two established drugs were tested in the assay. Ivabradine, an approved HCN channel pore blocker and gabapentin, is known to bind to HCN4 channels in preference to other isoforms with an unknown mode of action. As expected, ivabradine had no impact on ligand binding. In addition, gabapentin had no influence on 8-Fluo-cAMP’s binding to HCN4-CNBD. This is the first indication that gabapentin is not interacting with this part of the HCN4 channel. The ligand-binding assay as described can be used to determine binding constants for ligands such as cAMP and derivatives. It could also be applied for the identification of new ligands binding to the HCN4-CNBD.
format Online
Article
Text
id pubmed-10224427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102244272023-05-28 A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands Wojciechowski, Magdalena N. Schreiber, Sebastian Jose, Joachim Pharmaceuticals (Basel) Article Hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels are promising therapeutic targets because of their association with the genesis of several diseases. The identification of selective compounds that alter cAMP-induced ion channel modulation by binding to the cyclic nucleotide-binding domain (CNBD) will facilitate HCN channel-specific drug development. In this study, a fast and protein purification-free ligand-binding approach with a surface-displayed HCN4 C-Linker-CNBD on E. coli is presented. 8-Fluo-cAMP ligand binding was monitored by single-cell analysis via flow cytometry, and a K(d)-value of 173 ± 46 nM was determined. The K(d) value was confirmed by ligand depletion analysis and equilibrium state measurements. Applying increasing concentrations of cAMP led to a concentration-dependent decrease in fluorescence intensity, indicating a displacement of 8-Fluo-cAMP. A K(i)-value of 8.5 ± 2 µM was determined. The linear relationship of IC(50) values obtained for cAMP as a function of ligand concentration confirmed the competitive binding mode: IC(50): 13 ± 2 µM/16 ± 3 µM/23 ± 1 µM/27 ± 1 µM for 50 nM/150 nM/250 nM/500 nM 8-Fluo-cAMP. A similar competitive mode of binding was confirmed for 7-CH-cAMP, and an IC(50) value of 230 ± 41 nM and a K(i) of 159 ± 29 nM were determined. Two established drugs were tested in the assay. Ivabradine, an approved HCN channel pore blocker and gabapentin, is known to bind to HCN4 channels in preference to other isoforms with an unknown mode of action. As expected, ivabradine had no impact on ligand binding. In addition, gabapentin had no influence on 8-Fluo-cAMP’s binding to HCN4-CNBD. This is the first indication that gabapentin is not interacting with this part of the HCN4 channel. The ligand-binding assay as described can be used to determine binding constants for ligands such as cAMP and derivatives. It could also be applied for the identification of new ligands binding to the HCN4-CNBD. MDPI 2023-05-07 /pmc/articles/PMC10224427/ /pubmed/37242492 http://dx.doi.org/10.3390/ph16050710 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wojciechowski, Magdalena N.
Schreiber, Sebastian
Jose, Joachim
A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title_full A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title_fullStr A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title_full_unstemmed A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title_short A Novel Flow Cytometry-Based Assay for the Identification of HCN4 CNBD Ligands
title_sort novel flow cytometry-based assay for the identification of hcn4 cnbd ligands
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224427/
https://www.ncbi.nlm.nih.gov/pubmed/37242492
http://dx.doi.org/10.3390/ph16050710
work_keys_str_mv AT wojciechowskimagdalenan anovelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands
AT schreibersebastian anovelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands
AT josejoachim anovelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands
AT wojciechowskimagdalenan novelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands
AT schreibersebastian novelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands
AT josejoachim novelflowcytometrybasedassayfortheidentificationofhcn4cnbdligands